Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Cross-sectional
Other

Non-interventional study design, other

Retrospective survey, Post-authorisation safety study
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(R06AA02) diphenhydramine
diphenhydramine
(R06AA09) doxylamine
doxylamine

Medical condition to be studied

Fall
Population studied

Short description of the study population

Resident physicians who were general practitioners/internists with no specialisation or neurologists.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

500
Study design details

Main study objective

The primary objective of this study is to investigate a possible causal relationship between falls in patients at ≥ 65 years of age and the intake of antihistamines of the first generation with sedative effect.

Outcomes

Incidence and causes of falls in older patients in connection with the intake of antihistamines of the first generation with sedative effect.

Data analysis plan

Data evaluation by means of descriptive statistics.